NIH CFAR Administrative Supplements

The DC CFAR promotes periodic NIH CFAR Administrative Supplement opportunities to our membership when we are made aware of them. These supplements are offered by the NIH to spur research in high priority areas.

The center communicates open requests for applications through weekly member emails. Become a member of the DC CFAR to learn more about NIH CFAR Administrative Supplements.

DC CFAR investigators have been very successful in competing for NIH CFAR Administrative Supplements to date. A listing of all currently and previously funded investigators and abstracts of their projects are provided.

View the archive to learn more about awards given in 2013 or earlier.

2021 Awards

2019 Awards

Dr. Carlos Rodriguez-Diaz

Puerto Rico-DC CFAR government-community-academic partnership (GCAP) for comprehensive HIV prevention and response

Carlos Rodriguez-Diaz, PhD, MPHE, MCHES (GW) has received an NIH CFAR Administrative Supplement entitled, “Puerto Rico-DC CFAR government-community-academic partnership (GCAP) for comprehensive HIV prevention and response”.
Sarah Henn

A City-Wide Approach to HIV Pre-Exposure Prophylaxis (PrEP) Scale-Up in Multiple High-Risk Communities in Washington D.C.

Sarah Henn, MD, MPH (Whitman-Walker Health) has been awarded an NIH CFAR Administrative supplement titled, “A City-Wide Approach to HIV Pre-Exposure Prophylaxis (PrEP) Scale-Up in Multiple High-Risk Communities in Washington D.C.” This project will address the “Prevent” pillar of the nationwide Ending the HIV (EHE) initiative.

The Development of Responsive Health Department HIV Data to Action Strategies through Community Engagement

Adam Allston, PhD, MPH, MSW and Brittani Saafir Callaway, PhD, MPH (DC Health) have been awarded a NIH CFAR Administrative Supplement titled, “The Development of Responsive Health Department HIV Data to Action Strategies through Community Engagement.”
Dr. Rupali Doshi

Citywide Expansion of Rapid Antiretroviral Therapy Initiation in the District of Columbia

Rupali Doshi, MD, MS (DC Health) has received an NIH CFAR Administrative Supplement entitled, “Citywide Expansion of Rapid Antiretroviral Therapy Initiation in the District of Columbia.

2018 Awards

Dr. Lynch

Implications of time to ART for antibody-based cure strategies

Rebecca Lynch, PhD, has received an NIH CFAR Administrative Supplement entitled, "Implications of time to ART for antibody-based cure strategies" to study methods to restrict and/or clear persistent viral reservoirs for individuals treated using antiretroviral therapy (ART).

2016 Awards

Real-time Phylodynamic Analysis of HIV in Washington, DC

Amanda Castel, MD, MPH, and Marcos Perez-Losada, PhD, MS have received an NIH CFAR Administrative Supplement to study HIV transmission patterns in Washington, DC to better identify which subpopulations and geographic areas are at highest risk for transmission and potential spread.

2015 Awards

Advancing Pre-exposure Prophylaxis (PrEP) Delivery among Black MSM in the District of Columbia

Marc Siegel, MD has received an NIH CFAR Administrative supplement to study whether a novel culturally competent clinic intervention can increase the uptake of pre-exposure prophylaxis (PrEP) to prevent HIV infection in black and young men who have sex with men. This population are among the only US populations to have recently experienced a significant increase in the number of incident HIV infections.

Impairment of ABCA1 glycosylation as a pathogenic mechanism in Nef-induced atherosclerosis

Radoslav Goldman, PhD has received an NIH CFAR Administrative supplement to characterize the role of glycosylation in ABCA1 functionality. ABCA1 is a key anti-atherogenic factor responsible for HDL production and cholesterol efflux. ABCA1 is targeted by HIV-1 Nef, which impairs ABCA1 maturation. Maturation of ABCA1 is tightly linked to its glycosylation, but detailed characterization of the role of glycosylation in ABCA1 functionality has not been done. Dr. Radoslav seeks to close this gap in our knowledge, providing the basis for future therapeutic efforts.

Contact

Brandi Robinson

Brandi Robinson
Senior Research Program Manager
202-994-4730
[email protected]